Biotech DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development February 13, 2025
Biotech Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 February 12, 2025
Biotech Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China February 11, 2025
Biotech BioRay’s ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA February 10, 2025
Biotech AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE February 9, 2025
Biotech Government of Canada invests $6 million to drive growth in B.C.’s life sciences sector February 8, 2025
Biotech Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 February 7, 2025
Biotech Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion February 4, 2025